Provisional Licensing Changes: Reduced Barriers or New Challenges?
Legislators have been scrambling this year to address huge challenges faced by the industry, with banking, social equity, and the expiration of thousands of temporary licenses being just a few of the top concerns.
Written by: An-Chi Tsou, PhD
When the FDA Met CBD: What Comes Next?
Faced with relentless public pressure and likely the reality of CBD everywhere, including in a topical in CVS and Walgreens, the FDA is opening the door to regulating CBD.
Written by: Jessica McElfresh, Esq.
Tax Issues Surrounding Arm’s Length vs. Non-arm’s Length Transactions
With 280E, it’s clear the Feds want to eviscerate cannabis business owners, which is scary and unfair, but not confusing.
Written by: Abraham Finberg, CPA and Simon Menkes, CPA
The Decriminalization of Magic Mushrooms
Welcome to a murky new movement to bring psychedelics out of the shadows and into a medical and research forefront.